Chronic lymphocytic leukaemia; no small Feb Feb no Idelalisib* Zydelig® Aus 4 Yes 29 None no funding no funding lymphocytic 2015 no 2016 registration lymphoma; funding follicular lymphoma in Nov 2009, stromal July 2010, tumours; approved case by in March outside outside Aus and case June 2011 July Imatinib Glivec® 10 Yes 13 None funding April 2014 funding NZ application 2009 extension 2010 restrictions restrictions made to the in March 2012, company approved in Nov 2012 Nov outside Aus and Metastatic July March Ipilimumab Yervoy® 6 Yes 38 None 2012, funding no funding no funding NZ melanoma 2011 2012 listed in restrictions August 2013
Idelalisib* Zydelig® Aus 4 Yes Chronic lymphocytic leukaemia; small lymphocytic lymphoma; follicular lymphoma 29 None Feb 2015 no funding no no funding Feb 2016 no funding no registration Imatinib Glivec® Aus and NZ 10 Yes stromal tumours; case by case application made to the company 13 None June 2009 in Nov 2009, July 2010, approved in March 2011 extension in March 2012, approved in Nov 2012 outside funding restrictions July 2010 April 2014 outside funding restrictions Ipilimumab Yervoy® Aus and NZ 6 Yes Metastatic melanoma 38 None July 2011 Nov 2012, listed in August 2013 outside funding restrictions March 2012 no funding no funding
1-s2.0-S0168851017303457-mmc1.docx